145 related articles for article (PubMed ID: 10085148)
21. Regulation of mitogen-activated protein kinase phosphatase-1 induction by insulin in vascular smooth muscle cells. Evaluation of the role of the nitric oxide signaling pathway and potential defects in hypertension.
Begum N; Ragolia L; Rienzie J; McCarthy M; Duddy N
J Biol Chem; 1998 Sep; 273(39):25164-70. PubMed ID: 9737976
[TBL] [Abstract][Full Text] [Related]
22. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells.
Franklin CC; Kraft AS
J Biol Chem; 1997 Jul; 272(27):16917-23. PubMed ID: 9202001
[TBL] [Abstract][Full Text] [Related]
23. ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells.
Sarközi R; Miller B; Pollack V; Feifel E; Mayer G; Sorokin A; Schramek H
J Cell Physiol; 2007 Apr; 211(1):88-100. PubMed ID: 17131384
[TBL] [Abstract][Full Text] [Related]
24. Perinatal hypothyroidism impairs the normal transition of GLUT4 and GLUT1 glucose transporters from fetal to neonatal levels in heart and brown adipose tissue. Evidence for tissue-specific regulation of GLUT4 expression by thyroid hormone.
Castelló A; Rodríguez-Manzaneque JC; Camps M; Pérez-Castillo A; Testar X; Palacín M; Santos A; Zorzano A
J Biol Chem; 1994 Feb; 269(8):5905-12. PubMed ID: 8119934
[TBL] [Abstract][Full Text] [Related]
25. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
Franklin CC; Kraft AS
Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
[TBL] [Abstract][Full Text] [Related]
26. Mitogen-activated protein kinases and mitogen-activated protein kinase phosphatases mediate the inhibitory effects of all-trans retinoic acid on the hypertrophic growth of cardiomyocytes.
Palm-Leis A; Singh US; Herbelin BS; Olsovsky GD; Baker KM; Pan J
J Biol Chem; 2004 Dec; 279(52):54905-17. PubMed ID: 15494319
[TBL] [Abstract][Full Text] [Related]
27. [A study on the regulatory mechanisms of mitogen-activated protein kinase phosphatase-1 in hypoxia inducible factor-1 trans-activation].
Qiao TD; Liu CJ; Shi YQ; DU YL; Han S; Fan DM
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):555-9. PubMed ID: 15949338
[TBL] [Abstract][Full Text] [Related]
28. Regulation of mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle cells.
Bokemeyer D; Lindemann M; Kramer HJ
Hypertension; 1998 Oct; 32(4):661-7. PubMed ID: 9774360
[TBL] [Abstract][Full Text] [Related]
29. Regulation of glucose transporter expression in cardiac myocytes: p38 MAPK is a strong inducer of GLUT4.
Montessuit C; Rosenblatt-Velin N; Papageorgiou I; Campos L; Pellieux C; Palma T; Lerch R
Cardiovasc Res; 2004 Oct; 64(1):94-104. PubMed ID: 15364617
[TBL] [Abstract][Full Text] [Related]
30. Essential role of calcium in the regulation of MAP kinase phosphatase-1 expression.
Scimeca JC; Servant MJ; Dyer JO; Meloche S
Oncogene; 1997 Aug; 15(6):717-25. PubMed ID: 9264412
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes.
He Q; LaPointe MC
Hypertension; 1999 Jan; 33(1 Pt 2):283-9. PubMed ID: 9931118
[TBL] [Abstract][Full Text] [Related]
32. MAP kinase phosphatase-1 gene transcription in rat neuroendocrine cells is modulated by a calcium-sensitive block to elongation in the first exon.
Ryser S; Tortola S; van Haasteren G; Muda M; Li S; Schlegel W
J Biol Chem; 2001 Sep; 276(36):33319-27. PubMed ID: 11423551
[TBL] [Abstract][Full Text] [Related]
33. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W; Pew T; Zou M; Pang D; Conzen SD
J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
[TBL] [Abstract][Full Text] [Related]
34. Ras and rho are required for galphaq-induced hypertrophic gene expression in neonatal rat cardiac myocytes.
Hines WA; Thorburn A
J Mol Cell Cardiol; 1998 Mar; 30(3):485-94. PubMed ID: 9515026
[TBL] [Abstract][Full Text] [Related]
35. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Aoki H; Richmond M; Izumo S; Sadoshima J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
[TBL] [Abstract][Full Text] [Related]
36. Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer.
Durham PL; Russo AF
Mol Endocrinol; 1998 Jul; 12(7):1002-9. PubMed ID: 9658404
[TBL] [Abstract][Full Text] [Related]
37. Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation.
Behrooz A; Ismail-Beigi F
J Biol Chem; 1997 Feb; 272(9):5555-62. PubMed ID: 9038162
[TBL] [Abstract][Full Text] [Related]
38. c-Jun N-terminal kinase-interacting protein 1 inhibits gene expression in response to hypertrophic agonists in neonatal rat ventricular myocytes.
Finn SG; Dickens M; Fuller SJ
Biochem J; 2001 Sep; 358(Pt 2):489-95. PubMed ID: 11513749
[TBL] [Abstract][Full Text] [Related]
39. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells.
Seternes OM; Johansen B; Moens U
Mol Endocrinol; 1999 Jul; 13(7):1071-83. PubMed ID: 10406459
[TBL] [Abstract][Full Text] [Related]
40. Regulation of a heterologous glucose transporter promoter in chicken embryo fibroblasts.
Steane SE; Mylott D; White MK
Biochem Biophys Res Commun; 1998 Nov; 252(2):318-23. PubMed ID: 9826527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]